The Source — the HYDROGENYX Journal
Bifidobacterium en moleculaire waterstof
Paul Fournier
Bifidobacterium is one of the most studied bacterial genera in the human gut microbiota. Its abundance declines with age, during antibiotic therapy, and with a Western diet. The Yang 2017 study observed an increase in Bifidobacterium in mice given hydrogen-rich water (study result, not a promise of individual outcome). What should we take away from this?
Bifidobacterium — who are they?
The genus Bifidobacterium comprises about fifty strictly anaerobic, Gram-positive, Y-shaped species. The main ones in humans are: B. longum, B. breve, B. bifidum, B. adolescentis, B. infantis. They mainly colonize the colon (10⁸ to 10¹⁰ CFU/g of stool in healthy adults).
These bacteria are considered beneficial commensals: they ferment dietary fibers into short-chain fatty acids (acetate, lactate, which are then converted into butyrate by other genera), produce B and K vitamins, strengthen the intestinal barrier, stimulate the mucosal immune system, and inhibit pathogens through competition.
The abundance of Bifidobacterium is considered a marker of intestinal health: low in patients with IBD, obesity, type 2 diabetes, depression. High in healthy centenarians (Okinawa, Sardinia cohorts).
Why Bifidobacterium declines with age
Several mechanisms converge to explain the progressive reduction in bifidogenic abundance with age:
- Reduced mucin production: the colonic mucus layer thins with age, reducing the habitat for Bifidobacterium
- Increased intestinal oxidative stress: strict anaerobic bacteria are sensitive to ROS
- Reduced intake of fermented fibers: Western diet depleted in prebiotics
- Accumulated antibiotic therapies over a lifetime
- Changes in colonic pH with age
This decline is associated with a decrease in overall microbial diversity and the emergence of inflammaging — the chronic low-grade inflammation characteristic of aging.
The Yang 2017 study in detail
Yang Y, et al. J Microbiol Biotechnol. 2017;27(11):2087-2095
Male C57BL/6 mice, 8 weeks old at baseline. Three groups (n=10 each): control (ordinary water), hydrogen-rich water 0.8 ppm, hydrogen-rich water 1.2 ppm. Duration 4 weeks. 16S rRNA V3-V4 region sequencing on fecal extracts at T0 and T+4.
Key results:
| Bacterial genus | Control | H₂ 0.8 ppm | H₂ 1.2 ppm |
|---|---|---|---|
| Bifidobacterium | reference | +22 % | +34 % |
| Lactobacillus | reference | +18 % | +27 % |
| Proteobacteria (pro-inflammatory) | reference | −12 % | −19 % |
| Alpha diversity (Shannon) | reference | +4.1 % | +7.8 % |
| F/B Ratio | 2.1 | 1.8 | 1.6 |
Proposed mechanism
Why do Bifidobacterium proliferate under H₂? Three synergistic explanations:
1. Favorable redox potential
Bifidobacterium are strictly anaerobic. They thrive in a low redox potential environment (Eh < −200 mV). The presence of dissolved H₂ in the colon lowers this potential and neutralizes local oxidized species, creating a more favorable habitat for their growth.
2. Protection against oxidative stress
Bifidobacterium have few intrinsic antioxidant enzymes (no catalase, little SOD). They are therefore very vulnerable to oxidative stress. H₂ acts as an exogenous antioxidant that directly protects them.
3. Modulation of competitors
Proteobacteria (E. coli, Klebsiella, certain enterobacteria) are facultative anaerobes that thrive when oxygen or oxidized species increase in the colon. H₂ reduces this ecological niche, making room for beneficial strict anaerobes.
Confirmation in humans
The Ostojic 2018 study (cited in our microbiota cornerstone) repeated this protocol in 20 healthy adult human subjects. 1.5 ppm, 1 L/day, 8 weeks. Results: significant increase in Shannon alpha diversity (+8.3%), enrichment in Faecalibacterium prausnitzii (butyrate-producing genus, health marker), a trend towards increased Bifidobacterium (not significant, likely due to lack of statistical power for n=20).
Other human studies are exploring this bifidogenic effect, with still heterogeneous results depending on the populations and durations studied (results observed in studies — not a promise of individual outcomes).
Comparison with conventional probiotics
Conventional probiotics (Bifidobacterium capsules at doses of 10 billion CFU) transiently increase bifidogenic abundance, but persistent colonization is rare. The majority of ingested Bifidobacterium transit and are eliminated within 2 to 4 weeks after discontinuation.
H₂ acts differently: it does not provide new bacteria but modifies the environment to favor those already present in small quantities. This is more sustainable, but it assumes that residual Bifidobacterium are still present to proliferate. The two approaches are complementary.
| Approach | Advantage | Limitation |
|---|---|---|
| Probiotic capsules | Rapid intake | Transient colonization |
| H₂ hydrogen-rich water | Sustainable modulation | Depends on existing bacterial flora |
| Prebiotics (inulin, GOS) | Substrate nourishment | Variable digestive tolerance |
| Synbiotic (all 3) | Synergistic | Protocol consistency |
Recommended synbiotic protocol
For those who want to maximize bifidogenic abundance:
- Morning on an empty stomach: 500 mL of HYDROGENYX Flask hydrogen-rich water (advertised concentration up to 9,000 PPB, DPD control per batch)
- Breakfast: 1 multi-strain probiotic capsule including 2-3 Bifidobacterium strains (minimum 10 billion CFU)
- Evening: 5 to 10 g inulin or fructo-oligosaccharides (start at 2 g and gradually increase to avoid bloating)
Intensive course duration: 12 weeks. Maintenance thereafter: daily H₂, probiotic course for 4 weeks every 3 months, inulin as tolerated digestively.
If you suffer from intestinal hyperpermeability, the combined protocol is detailed in intestinal hyperpermeability — H₂ + L-glutamine protocol.
Limitations to be aware of
Bifidobacterium are not the answer to everything. Gut health depends on a dynamic balance between hundreds of bacterial genera. Increasing Bifidobacterium does not guarantee clinical improvement in everyone: some profiles have an initial microbiota already saturated with Bifidobacterium and do not respond as much.
A before/after microbiota test remains the most informative tool. Cost in France 2026: 130 to 250 euros (Biomes, MyMicrobiome, Floranet). 16S rRNA method is accessible. Shotgun metagenomics is more precise but expensive (400 to 800 euros).
Conclusion
The increase in Bifidobacterium observed in mice (Yang 2017) is the subject of further human studies, with still heterogeneous results (results observed in studies — not a promise of individual outcome). The proposed mechanism is coherent. For those interested in their microbiota balance, the combination of hydrogen-rich water + probiotic + prebiotic can be tested for 12 weeks, ideally with objective measurement and the advice of a healthcare professional.
HYDROGENYX Flask
The hydrogen ritual, ready in 5 minutes.
Up to ~9,000 ppb of dissolved molecular hydrogen (manufacturer's data), verifiable at home with a DPD test. 400 ml, touch screen, wireless charging base included.
60-day money-back guarantee · 5-year cell warranty · 4× Klarna
The HYDROGENYX Flask is a water preparation device, not a medical device. It does not prevent, treat, or cure any disease.
To go further: the science of hydrogen · the comparison · the FAQ